DIA Annual Canadian Meeting

Transformation with Collaboration

戻る Agenda

Session 3: Track B: Canadian Trends in Fostering Clinical Trial Research

Session Chair(s)

Fiona M Frappier, PhD

Senior Policy Analyst

Health Canada, Canada

The session will provide an overview of key initiatives to enhance the number and quality of trials underway in Canada. Factors impacting the clinical trials environment and opportunities to improve our healthcare innovation capabilities in Canada will be identified and described. Key outlooks will be reflected from provincial, contract research organization, and national coordinating center perspectives.

Learning Objective : At the conclusion of this session, participants should be able to:
Identify resources and tools available in the Canadian innovation ecosystem
Discuss how to leverage strengths between industry, government, and academia
Discuss options to further enhance Canadian clinical trials environment

Speaker(s)

Update on Health Canada’s Clinical Data Sharing Initiative

Marcin Boruk, MBA, MSc

Health Canada, Canada

Manager RMOD, HFPB

Enhancing Research Participant Protection in Canada Through Accreditation

Janice Parente, PhD

Orion Human Research Accreditation, Canada

President and CEO

Clinical Trials: The Changing Landscape - Understanding and Adapting

Susan Marlin, MSc

Clinical Trials Ontario, Canada

President & CEO